Mouse CD‐RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma

A cDNA encoding a novel protein has been previously isolated from two independent sources: melanoma cell cultures and chondrocytes. The protein from human melanoma cell lines and tumors is called melanoma inhibitory activity (MIA) (Blesch et al. [1994] Cancer Res. 54:5695–5701) and the protein from primary bovine chondrocytes and cartilaginous tissues is called cartilage‐derived retinoic acid‐sensitive protein (CD‐RAP) (Dietz and Sandell [1996] J. Biol. Chem. 271:3311–3316). In order to investigate the gene regulation and function of CD‐RAP/MIA, the mouse gene locus was isolated and analyzed. Developmental expression was determined by in situ hybridization to mouse embryos. Expression was limited to cartilaginous tissues and was initiated with the advent of chondrogenesis, remaining abundant throughout development. The mouse gene was isolated and sequenced from a 129Sv library and sequenced directly from an additional strain, B6C3Fe. The mouse CD‐RAP/MIA gene is 1.5 kbp and consists of four exons. The promoter sequence of the gene contains many potential regulatory domains including 8 basic helix‐loop‐helix protein‐binding domains and an AT‐rich domain, both motifs shown to be present in the cartilage‐specific enhancer of the type II procollagen gene. Other potential cis‐acting motifs include binding sites for GATA‐1, NF‐IL6, PEA3, w‐elements, NFκB, Zeste and Sp1. The gene, called cdrap, was localized to the end of an arm of chromosome 7 at the same site as the transforming growth factor β1 (Tgf‐β1) and the glucose phosphate isomerase 1 (Gpi1) genes. Potential mouse mutants that mapped to the same region of chromosome 7 were identified. Two of the potential mutants with skeletal phenotypes were sequenced, pudgy (pu) and extra toes with spotting (Xsj); however, no mutations were found in the coding sequence. To determine whether CD‐RAP/MIA is associated with tumors of cartilage, mRNAs from a variety of rodent tissues and cell lines were screened. Expression was detected in a rodent tumor, the Swarm rat chondrosarcoma and a chondrosarcoma cell line derived from it, but not in other tissues or tumors of non‐cartilage origin. Immunolocalization revealed CD‐RAP/MIA protein localized in cartilage only. These results show that the normal expression of CD‐RAP/MIA is limited to cartilage; however, pathologically, it is expressed both in melanoma and chondrosarcoma. The restricted expression of CD‐RAP/MIA may provide an opportunity to monitor cartilage metabolic activity as well as the tumor activity of melanoma and chondrosarcoma. Dev. Dyn. 208:516–525, 1997. © 1997 Wiley‐Liss, Inc.

[1]  A. Bosserhoff,et al.  Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH). , 1996, Genomics.

[2]  P H Krebsbach,et al.  Identification of a Minimum Enhancer Sequence for the Type II Collagen Gene Reveals Several Core Sequence Motifs in Common with the Link Protein Gene (*) , 1996, The Journal of Biological Chemistry.

[3]  L. Sandell,et al.  Cloning of a Retinoic Acid-sensitive mRNA Expressed in Cartilage and during Chondrogenesis (*) , 1996, The Journal of Biological Chemistry.

[4]  A. Bosserhoff,et al.  Structure and Promoter Analysis of the Gene Encoding the Human Melanoma-inhibiting Protein MIA (*) , 1996, The Journal of Biological Chemistry.

[5]  H. Bloemers,et al.  Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. , 1995, Cancer research.

[6]  N. Perrimon,et al.  The porcupine gene is required for wingless autoregulation in Drosophila. , 1995, Development.

[7]  M. Altherr,et al.  Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene. , 1995, Genomics.

[8]  V. Lefebvre,et al.  Use of a New Rat Chondrosarcoma Cell line to Delineate a 119-Base Pair Chondrocyte-specific Enhancer Element and to Define Active Promoter Segments in the Mouse Pro-α1(II) Collagen Gene (*) , 1995, The Journal of Biological Chemistry.

[9]  R. Schüle,et al.  Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. , 1995, Development.

[10]  L. Sandell,et al.  Collagen gene expression during development of avian synovial joints: Transient expression of types II and XI collagen genes in the joint capsule , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  A. Weiland,et al.  Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  A. Bosserhoff,et al.  Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. , 1994, Cancer research.

[13]  L. Sandell,et al.  Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non‐cartilaginous tissues during early mouse development , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  E. Appella,et al.  Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. , 1992, The Journal of biological chemistry.

[15]  J. Darnell,et al.  Murine chromosomal location of four hepatocyte-enriched transcription factors: HNf-3α, HNF-3β, HNF-3γ, and HNF-4 , 1992 .

[16]  W. Horton,et al.  Identification of a cis-acting sequence in the collagen II enhancer required for chondrocyte expression and the binding of a chondrocyte nuclear factor. , 1991, The Journal of biological chemistry.

[17]  M. Goldring,et al.  Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide , 1991, The Journal of cell biology.

[18]  N. Copeland,et al.  Development and applications of a molecular genetic linkage map of the mouse genome. , 1991, Trends in genetics : TIG.

[19]  M. Ryan,et al.  Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. , 1990, The Journal of biological chemistry.

[20]  N. Copeland,et al.  Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus , 1982, Journal of virology.

[21]  S. Hsu,et al.  The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.

[22]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[23]  K. Meyer,et al.  Mucopolysaccharide and protein--polysaccharide of a transplantable rat chondrosarcoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Tenen,et al.  Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. , 1996, Current topics in microbiology and immunology.

[25]  P. Defossez,et al.  [Transcription factors of the PEA3 group in mammary cancer]. , 1995, Annales d'Endocrinologie.

[26]  J. Kollár,et al.  Modulation of extracellular matrix gene expression in bovine high-density chondrocyte cultures by ascorbic acid and enzymatic resuspension. , 1994, Archives of biochemistry and biophysics.

[27]  D. Baltimore,et al.  32 The Helix-Loop-Helix Motif: Structure and Function , 1992 .

[28]  Frederick M. Ausubel,et al.  Short protocols in molecular biology : a compendium of methods from Current protocols in molecular biology , 1989 .

[29]  E. L. Green Linkage, recombination and mapping , 1981 .

[30]  M. C. Green,et al.  Catalog of mutant genes and polymorphic loci. , 1981 .